Plastic Surgery Doctors in Paradise Valley, AZ Accepting Medicare

6 Plastic Surgery doctors found. Showing 1 - 6

Terry R Maffi I, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5410 N Scottsdale Rd, Suite E200, Paradise Valley, AZ 85253 Phone: 480-505-6430    Fax: 480-505-6429

Dr. Stephen Paul Beals, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5410 N Scottsdale Rd, Suite E-400, Paradise Valley, AZ 85253 Phone: 480-947-6788    Fax: 602-926-2597

Dr. Mark Gruszynski, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5410 N Scottsdale Rd Ste A200, Paradise Valley, AZ 85253 Phone: 480-848-2757

Dr. Jack A Friedland, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5410 N Scottsdale Road, Suite E200, Paradise Valley, AZ 85253 Phone: 480-905-1700    Fax: 480-505-6429

Daniel Shapiro, Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5410 N Scottsdale Rd, Ste. F100, Paradise Valley, AZ 85253 Phone: 480-451-1700    Fax: 480-451-1665

Dr. Robert Cohen, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5410 N Scottsdale Rd, Suite A-500, Paradise Valley, AZ 85253 Phone: 480-423-1973    Fax: 480-423-1977

News Archive

Michigan Senate approves expansion of Medicaid

The vote was a victory for Republican Gov. Rick Snyder, who pushed for passage, bucking the sentiments of many in his party. It is now all but certain that nearly half a million residents will gain coverage when Michigan joins the list of states opting to expand the program under the federal health law.

Study: Thousands of women get unnecessary mammograms before breast reduction surgery

Each year, thousands of younger women with no known risk of breast cancer get mammograms before having breast reduction surgery.

Confidence in COVID-19 restrictions leads to good mental health

In March 2020, Covid-19 was declared a global pandemic, and governments around the world imposed restrictions to reduce the spread of the Coronavirus.

Positive Phase 2 data from Nektar Therapeutics' NKTR-102 study in women with platinum-resistant ovarian cancer

Nektar Therapeutics today announced preliminary progression-free survival data from the first stage of a two-stage Phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients were enrolled with platinum-resistant disease and were evaluable for the secondary endpoint of progression-free survival (PFS).

Read more Medical News

› Verified 6 days ago